Notice of a General Meeting, to be held at the Company’s Registered Office at 9:30am on 19 December 2014 has today been sent to Shareholders and is now available from the investor section of the Sopheon website at www.sopheon.com, in the form of a circular that describes proposals for a Share Subdivision, following the recent Share Consolidation. Full details of the proposals, including definitions of capitalised terms not defined in this announcement, can be found in the circular. The proposed timetable is given below. Due to differences in the settlement mechanisms between the Netherlands and the UK, the record date set out in the proposed timetable for shares in the Netherlands is two days later than in the UK. Notwithstanding the foregoing, trading in the New Ordinary Shares will commence on both AIM and Alternext on 22 December 2014.
| Date of circular | 2 December 2014 |
| Latest time and date for receipt of Proxy Forms | 9.30 a.m. on 17 December 2014 |
| General Meeting | 9.30 a.m. on 19 December 2014 |
| UK Record Date for the Share Subdivision | 5.00 p.m. on 19 December 2014 |
| Existing Ordinary Shares disabled in CREST and share register closed | 5.00 p.m. on 19 December 2014 |
| Admission effective and dealings commence on AIM and Alternext in New Ordinary Shares | 8.00 a.m. on 22 December 2014 |
| CREST accounts credited with New Ordinary Shares | 22 December 2014 |
| Netherlands Record Date for Share Subdivision | 23 December 2014 |
| Certificates in respect of New Ordinary Shares dispatched on or before | 9 January 2015 |
For Further Information Contact:
| Barry Mence, Chairman | Sopheon plc | + 44 (0) 1483 685 735 |
| Arif Karimjee, CFO | Sopheon plc | + 44 (0) 1483 685 735 |
| Charlotte Stranner / Victoria Bates | finnCap | + 44 (0) 20 7600 1658 |
| Heather Armstrong | Newgate Threadneedle | + 44 (0) 20 7653 9842 |
| Claire Verhagen | Citigate First Financial | + 31 (0) 205 754 010 |
About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands.